Eli Lilly and Company
LLY
$839.96
$105.0614.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 354.48% | -67.30% | 32.28% | 2.43% | 3,914.81% |
| Total Depreciation and Amortization | 3.86% | 12.64% | 3.44% | 3.33% | -5.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -108.57% | 542.67% | -288.56% | -3.25% | -72.87% |
| Change in Net Operating Assets | -22,603.06% | 99.30% | 20.11% | 44.80% | -499.87% |
| Cash from Operations | -33.35% | 153.16% | 25.75% | 473.84% | -114.25% |
| Capital Expenditure | -10.76% | -10.28% | -24.18% | 7.87% | -10.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.01% | -10,029.77% | 86.30% | 76.37% | 61.64% |
| Cash from Investing | 52.04% | -82.14% | -86.71% | 59.73% | 5.07% |
| Total Debt Issued | -100.00% | -- | -100.00% | 40.44% | 4,636.49% |
| Total Debt Repaid | 198.48% | -212.92% | 152.56% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -360.41% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.19% | 0.16% | -0.27% | -14.84% | -0.19% |
| Other Financing Activities | 3.81% | -491.25% | 97.95% | -1,133.54% | -364.71% |
| Cash from Financing | -206.67% | -86.42% | 599.68% | -108.78% | 519.70% |
| Foreign Exchange rate Adjustments | -288.85% | 480.70% | -67.89% | -127.46% | 2,339.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.19% | -80.95% | 313.00% | -181.86% | 239.56% |